9Tasaki A, Asatani MO, Umezu H, et al. Differential diag- nosis of uterine smooth muscle tumors using diffusion-weigh- ted imaging: correlations with the apparent diffusion coeffi- cient and cell density [J]. Abdom Imaging, 2014.
10Juang CM, Yen MS, Homg HC, et al. Potential role of preoperative serum CA125 for the differential diagnosis be- tween uterine leiomyoma and uterine leiomyosareoma [J ] . Eur J Gynaecol Oncol, 2006, 27 (4) : 370-374.
2Lin J F,Slomovitz B M. Uterine sarcoma 2008[J]. CurrOncol Rep,2008,10( 6) : 512-518.
3Matoda M,Takeshima N,Nomura H,et al. The treat-ment of uterine leiomyosarcoma: clinical outcomes of 18cases and the effectiveness of chemotherapy[J]. Eur JGynaecol Oncol,2011,32( 6) : 647-650.
4Brewer Savannah K J,Demicco E G,Lusby K,et al.Dual targeting of m TOR and aurora—A kinase for thetreatment of uterine Leiomyosarcoma [J]. Clin CancerRes,2012,18( 17) : 4633-4645.
5Levy A,Medjhoul A,Caramella C,et al. Interest of dif-fusion-weighted echo-planar MR imaging and apparentdiffusion coefficient mapping in gynecological malignan-cies: a review[J]. J Magn Reson Imaging,2011,33( 5) :1020-1027.